Collaborative Network for Clinical Research on Immune Tolerance
Grant Opportunity Analysis
The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, is seeking applications to continue supporting the Collaborative Network for Clinical Research on Immune Tolerance. Funded through a cooperative agreement, the selected recipient will develop improved tolerogenic interventions to prevent and treat immune system-mediated diseases such as transplant rejection, autoimmune diseases, and asthma. The program's core work involves conducting clinical trials for promising tolerogenic strategies, investigating the basic mechanisms of human immune tolerance, and refining assays to monitor tolerance induction and loss. Eligible applicants include regional organizations, faith-based groups, US territories, and foreign institutions. The agency expects to award a single grant with an estimated total program funding of $21,986,000, and inquiries can be directed to ITN_UM1@mail.nih.gov ahead of the estimated closing date on January 29, 2027.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.